Business Context and Reporting Period
Company: Centrus Energy Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: June 17, 2025
Event: Amendment to the High-Assay, Low-Enriched Uranium (HALEU) Demonstration Cascade Completion and HALEU Operation Contract with the U.S. Department of Energy (DOE).
Key Financial Metrics
This filing does not report consolidated revenue, profit, cash flow, margins, debt, or liquidity metrics for the company. It focuses exclusively on the financial terms of a specific government contract amendment.
- Contract Value (Option 1a): Approximately $110,000,000 (exercised by DOE).
- Target Cost (Option 1a): $99,289,528.
- Target Fee (Option 1a): $8,704,218.
- Target Cost (Option 1b): $163,477,542 (subject to revision).
- Target Fee (Option 1b): $15,235,927 (subject to revision).
Material Changes
The DOE issued an amendment splitting the original first three-year option period ("Option 1") into two distinct periods:
- Option 1a: A one-year period. The DOE has exercised this option, extending the period of performance to June 30, 2026.
- Option 1b: A two-year period. The DOE has not yet exercised this option.
The amendment acknowledges that the estimated cost for Option 1b is insufficient due to known cost increases since the original contract award. Consequently, American Centrifuge Operating, LLC (ACO) must submit a revised cost proposal for review and negotiation before the DOE considers exercising Option 1b.
Outlook, Risks, and Contingencies
- Production Ownership: All HALEU produced under this contract belongs to the DOE.
- Cost Contingency: Future revenue from Option 1b is contingent upon the successful negotiation of a revised cost proposal to address inflation or cost increases.
- Appropriations: Continued production under option periods remains subject to the availability of Congressional appropriations.
- Disclosure: A press release regarding this amendment was issued on June 20, 2025, and is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the full text of the Amendment (expected in the next Form 10-Q) to confirm specific cost-plus incentive fee structures.
- Monitor the submission and approval status of the revised cost proposal for Option 1b.
- Confirm the timeline for the revised cost negotiation and its potential impact on the June 30, 2026 performance extension.
- Review the June 20, 2025 press release (Exhibit 99.1) for additional management commentary not detailed in the 8-K summary.